EndoGastric - Gastroenterological & Surgical Clinical Society Support Services

• American Gastroenterological Association (AGA) [1]

“[T]he three-year plus evidence is sufficient to demonstrate sustainable improvement in health outcomes, symptom relief, decrease in PPI utilization and improvement in esophageal pH with transoral fundoplication.

• Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) [2]

ARS is appropriate for individuals who: “(1) Failed medical management, (2) have complications of GERD and (3) have extra-esophageal manifestations (asthma, hoarseness, cough, chest pain, aspiration).”

• American Society for Gastrointestinal Endoscopy (ASGE) [3]

“Endoluminal antireflux techniques represent potentially new therapeutic indications for GI endoscopy.”

• American Society of General Surgeons (ASGS) [4]

“[T]ransoral fundoplication adheres to fundamental surgical principles. We also believe that there is a sufficient body of peer-reviewed literature that establishes transoral fundoplication as reasonable and medically necessary for a subset of patients who are candidates for surgical fundoplication; specifically, patients who either cannot obtain satisfactory relief from standard PPI therapy or who wish to avoid a lifetime of dependence on such medications, and present with a 2 centimeter or smaller hiatal hernia.”

• The American Medical Association (AMA) created a new Category I Current Procedural Terminology (CPT®) code—43210: EGD Esophagogastric Fundoplasty procedures. The new CPT code, which includes a procedure descriptor associated with the TIF procedure, took effect January 1, 2016. The application for the new code was jointly sponsored by four key specialty medical societies: American Gastroenterological Association (AGA), American College of Gastroenterology (ACG), American Society for Gastrointestinal Endoscopy (ASGE) and the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES).